Skip to content

Clinical trials

Not yet recruiting Phase 1/2 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Status: Not yet recruiting Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20232
20243
20257
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut Paoli-Calmettes2
Advenchen Pharmaceuticals, LLC.1
Akeso1
BioLite, Inc.1
CSPC Megalith Biopharmaceutical Co.,Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Eddingpharm (Zhuhai) Co., Ltd.1
Harbin Medical University1
Henan Cancer Hospital1
Hinova Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms31
Triple Negative Breast Neoplasms5
Endometrial Neoplasms3
Neoplasm Metastasis3
Colorectal Neoplasms2
Head and Neck Neoplasms2
Ovarian Neoplasms2
Brain Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.